1. Matriptase-2 Inhibits Breast Tumor Growth and Invasion and Correlates with Favorable Prognosis for Breast Cancer Patients
    Christian Parr et al, 2007, Clinical Cancer Research CrossRef
  2. Synthesis and biological evaluation of benzamide‐chalcone hybrids as potential c‐Met kinase and COX‐2 inhibitors
    Heena Bhojwani et al, 2023, Archiv der Pharmazie CrossRef
  3. Expression of serine protease SNC19/matriptase and its inhibitor hepatocyte growth factor activator inhibitor type 1 in normal and malignant tissues of gastrointestinal tract
    Lei Zeng, 2005, World Journal of Gastroenterology CrossRef
  4. Usnic Acid Benzylidene Analogues as Potent Mechanistic Target of Rapamycin Inhibitors for the Control of Breast Malignancies
    Hassan Y. Ebrahim et al, 2017, Journal of Natural Products CrossRef
  5. Design, synthesis, and biological evaluation of 2, 4-dichlorophenoxyacetamide chalcone hybrids as potential c-Met kinase inhibitors
    Heena Bhojwani et al, 2023, Medicinal Chemistry Research CrossRef
  6. Defect of Pro-Hepatocyte Growth Factor Activation by Fibroblasts in Idiopathic Pulmonary Fibrosis
    Sylvain Marchand-Adam et al, 2006, American Journal of Respiratory and Critical Care Medicine CrossRef
  7. The satellite cell as a companion in skeletal muscle plasticity:currency, conveyance, clue, connector and colander
    Judy E. Anderson, 2006, Journal of Experimental Biology CrossRef
  8. HGF synthesis in human lung fibroblasts is regulated by oncostatin M
    Murielle Cohen et al, 2006, American Journal of Physiology-Lung Cellular and Molecular Physiology CrossRef
  9. Harnessing Peptide-Functionalized Multivalent Gold Nanorods for Promoting Enhanced Gene Silencing and Managing Breast Cancer Metastasis
    Kasturee Chakraborty et al, 2023, ACS Applied Bio Materials CrossRef
  10. The Hepatocyte Growth Factor Regulatory Factors in Human Breast Cancer
    Christian Parr et al, 2004, Clinical Cancer Research CrossRef
  11. Met Receptor Signaling: A Key Effector in Esophageal Adenocarcinoma
    Mark R. Anderson et al, 2006, Clinical Cancer Research CrossRef
  12. Promoter Hypomethylation Is Responsible for Upregulated Expression of HAI-1 in Hepatocellular Carcinoma
    Xiaoxiao Du et al, 2019, Disease Markers CrossRef